PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Medical Research Center for Cardiology, Moscow, Russia.\', \'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences, Moscow, Russia; Sechenov Moscow State Medical University, Moscow, Russia.\', \'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences, Moscow, Russia; Lomonosov Moscow State University, Moscow, Russia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.18097/PBMC20216703244
?:hasPublicationType
?:journal
  • Biomeditsinskaia khimiia
is ?:pmid of
?:pmid
?:pmid
  • 34142531
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • [Peptide inhibitors of the interaction of the SARS-CoV-2 receptor-binding domain with the ACE2 cell receptor].
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all